secwatch.observer — SEC 8-K summary
======================================

Issuer:     PRECISION BIOSCIENCES INC (DTIL)
CIK:        0001357874
Form:       8-K
Filed at:   2025-11-12T23:59:59+00:00
Accession:  0001628280-25-051382
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Precision BioSciences prices $75M underwritten offering of common stock and warrants
--------------------------------------------------------------------------------

- Offering: 10.8M shares + 1.4M pre-funded warrants at $6.14/$6.139995 per unit; gross proceeds ~$75M.
- Net proceeds ~$70M after discounts and expenses, expected close Nov 12, 2025.
- Each whole warrant exercises at $7.25/share, 5-year term; 4.99% beneficial ownership cap applies.
- Proceeds to fund R&D for ARCUS gene editing pipeline and working capital.
- Guggenheim Securities sole book-runner; participation from Aberdeen, Bleichroeder, Driehaus, and others.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357874/000162828025051382/0001628280-25-051382-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357874/000162828025051382/dtil-20251110.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-051382

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer